Aktien

Läs mer:

Aktien

Nanologicas aktie är sedan 29 mars, 2022 listad på Nasdaq Stockholm Main Market. Aktien handlas via banker och fondkommissionärer.

Kortnamnet är NICA och ISIN-koden är SE 0005454873. Totala antalet aktier uppgår till 328 769 842 aktier och aktiekapitalet uppgår till 6 575 369,84 SEK med ett kvotvärde om 0,051 SEK per aktie.

About us

Nanologica is a Swedish life science group that offers advanced solutions in the development, manufacture and purification of pharmaceutical substances. By combining expertise in materials science, nanotechnology, and chemical process development, with services in contract development and manufacturing, Nanologica provides an integrated platform that supports the entire value chain from early development to commercial production of pharmaceutical substances. Nanologica’s offering enables efficient and scalable production of drug substances, with particular strength within complex molecules and peptide-based drugs, such as treatments for diabetes and obesity. The company positions itself as a long-term partner to the pharmaceutical industry, with the goal of enabling more patients around the world to have access to life-saving treatments and cost-effective medicines. The Group has about 70 employees and is headquartered in Södertälje. Nanologica’s share (ticker NICA) has been listed on Nasdaq Stockholm’s main market since 2022.